These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10198068)

  • 21. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
    Cheng N; Bhowmick NA; Chytil A; Gorksa AE; Brown KA; Muraoka R; Arteaga CL; Neilson EG; Hayward SW; Moses HL
    Oncogene; 2005 Jul; 24(32):5053-68. PubMed ID: 15856015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice.
    Goumans MJ; Zwijsen A; van Rooijen MA; Huylebroeck D; Roelen BA; Mummery CL
    Development; 1999 Aug; 126(16):3473-83. PubMed ID: 10409495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.
    Roarty K; Serra R
    Development; 2007 Nov; 134(21):3929-39. PubMed ID: 17898001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
    Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
    Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis.
    Snedeker SM; Brown CF; DiAugustine RP
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):276-80. PubMed ID: 1986376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in levels of mRNAs of transforming growth factor (TGF)-beta1, -beta2, -beta3, TGF-beta type II receptor and sulfated glycoprotein-2 during apoptosis of mouse uterine epithelium.
    Wada K; Nomura S; Morii E; Kitamura Y; Nishizawa Y; Miyake A; Terada N
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):367-75. PubMed ID: 9010342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of transforming growth factor-beta signaling in normal lung epithelial cells confers resistance to ionizing radiation.
    Reeves A; Zagurovskaya M; Gupta S; Shareef MM; Mohiuddin M; Ahmed MM
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):187-95. PubMed ID: 17448872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.
    Yang YA; Dukhanina O; Tang B; Mamura M; Letterio JJ; MacGregor J; Patel SC; Khozin S; Liu ZY; Green J; Anver MR; Merlino G; Wakefield LM
    J Clin Invest; 2002 Jun; 109(12):1607-15. PubMed ID: 12070308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.
    Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A
    J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of Alx4, a stromally-restricted homeodomain protein, impairs mammary epithelial morphogenesis.
    Joshi PA; Chang H; Hamel PA
    Dev Biol; 2006 Sep; 297(1):284-94. PubMed ID: 16916507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of TGF-beta type II receptor antisense RNA impairs TGF-beta signaling in vitro and promotes mammary gland differentiation in vivo.
    Lenferink AE; Magoon J; Pepin MC; Guimond A; O'Connor-McCourt MD
    Int J Cancer; 2003 Dec; 107(6):919-28. PubMed ID: 14601051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.
    Kordon EC; McKnight RA; Jhappan C; Hennighausen L; Merlino G; Smith GH
    Dev Biol; 1995 Mar; 168(1):47-61. PubMed ID: 7883078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
    Doré JJ; Edens M; Garamszegi N; Leof EB
    J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.
    Kundu SD; Kim IY; Yang T; Doglio L; Lang S; Zhang X; Buttyan R; Kim SJ; Chang J; Cai X; Wang Z; Lee C
    Prostate; 2000 May; 43(2):118-24. PubMed ID: 10754527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
    Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
    J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.